Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000334250 | SCV000345415 | uncertain significance | not provided | 2016-08-26 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001001791 | SCV001159442 | benign | Autosomal recessive nonsyndromic hearing loss 28 | 2018-08-01 | criteria provided, single submitter | clinical testing | |
Al Jalila Children’s Genomics Center, |
RCV001001791 | SCV001984069 | likely benign | Autosomal recessive nonsyndromic hearing loss 28 | 2020-02-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000334250 | SCV002412581 | benign | not provided | 2023-12-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003323498 | SCV004028843 | uncertain significance | not specified | 2023-07-14 | criteria provided, single submitter | clinical testing | Variant summary: TRIOBP c.2201C>T (p.Ser734Phe) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00082 in 249556 control chromosomes in the gnomAD database, including 1 homozygotes. To our knowledge, no occurrence of c.2201C>T in individuals affected with Autosomal Recessive Nonsyndromic Hearing Loss 28 and no experimental evidence demonstrating its impact on protein function have been reported. Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as benign/likely benign (n=3) and VUS (n=1). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. |
Prevention |
RCV003930190 | SCV004745247 | benign | TRIOBP-related disorder | 2019-10-29 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |